These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31162551)

  • 21. Incidence of cardiovascular diseases and associated risk factors among subjects with type 2 diabetes - an 11-year follow up study.
    Umamahesh K; Vigneswari A; Surya Thejaswi G; Satyavani K; Viswanathan V
    Indian Heart J; 2014; 66(1):5-10. PubMed ID: 24581089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease.
    Kranendonk ME; de Kleijn DP; Kalkhoven E; Kanhai DA; Uiterwaal CS; van der Graaf Y; Pasterkamp G; Visseren FL;
    Cardiovasc Diabetol; 2014 Feb; 13():37. PubMed ID: 24498934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular Risk Factors and Their Association with Vitamin D Deficiency in Mexican Women of Reproductive Age.
    Contreras-Manzano A; Villalpando S; García-Díaz C; Flores-Aldana M
    Nutrients; 2019 May; 11(6):. PubMed ID: 31141980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperglycemia and oxidative stress strengthen the association between myeloperoxidase and blood pressure.
    Van der Zwan LP; Scheffer PG; Dekker JM; Stehouwer CD; Heine RJ; Teerlink T
    Hypertension; 2010 Jun; 55(6):1366-72. PubMed ID: 20385972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes and natriuretic peptides.
    Seven E
    Dan Med J; 2015 Nov; 62(11):B5163. PubMed ID: 26522487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study.
    Neeland IJ; Singh S; McGuire DK; Vega GL; Roddy T; Reilly DF; Castro-Perez J; Kozlitina J; Scherer PE
    Diabetologia; 2018 Dec; 61(12):2570-2579. PubMed ID: 30159588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep apnea and galectin-3: possible sex-specific relationship.
    Singh M; Hanis CL; Redline S; Ballantyne CM; Hamzeh I; Aguilar D
    Sleep Breath; 2019 Dec; 23(4):1107-1114. PubMed ID: 30721387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma Leptin Levels and Risk of Incident Cancer: Results from the Dallas Heart Study.
    Gupta A; Herman Y; Ayers C; Beg MS; Lakoski SG; Abdullah SM; Johnson DH; Neeland IJ
    PLoS One; 2016; 11(9):e0162845. PubMed ID: 27636369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.
    Fleg JL; Evans GW; Margolis KL; Barzilay J; Basile JN; Bigger JT; Cutler JA; Grimm R; Pedley C; Peterson K; Pop-Busui R; Sperl-Hillen J; Cushman WC
    Hypertension; 2016 Oct; 68(4):888-95. PubMed ID: 27504006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study.
    Florido R; Kwak L; Echouffo-Tcheugui JB; Zhang S; Michos ED; Nambi V; Goldberg RB; Hoogeveen RC; Lazo M; Gerstenblith G; Post WS; Blumenthal RS; Coresh J; Folsom AR; Selvin E; Ballantyne C; Ndumele CE
    J Am Heart Assoc; 2022 May; 11(9):e023238. PubMed ID: 35491999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a low glycemic index diet versus a high-cereal fibre diet on markers of subclinical cardiac injury in healthy individuals with type 2 diabetes mellitus: An exploratory analysis of a randomized dietary trial.
    Ha V; Viguiliouk E; Kendall CWC; Balachandran B; Jenkins DJA; Kavsak PA; Sievenpiper JL
    Clin Biochem; 2017 Dec; 50(18):1104-1109. PubMed ID: 28958804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty liver index as a predictor of increased risk of cardiometabolic disease: finding from the Kuopio Ischaemic Heart Disease Risk Factor Study Cohort.
    Olubamwo OO; Virtanen JK; Pihlajamaki J; Mantyselka P; Tuomainen TP
    BMJ Open; 2019 Sep; 9(9):e031420. PubMed ID: 31492793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic and inflammatory profiles of biomarkers in obesity, metabolic syndrome, and diabetes in a Mediterranean population. DARIOS Inflammatory study.
    Fernández-Bergés D; Consuegra-Sánchez L; Peñafiel J; Cabrera de León A; Vila J; Félix-Redondo FJ; Segura-Fragoso A; Lapetra J; Guembe MJ; Vega T; Fitó M; Elosua R; Díaz O; Marrugat J
    Rev Esp Cardiol (Engl Ed); 2014 Aug; 67(8):624-31. PubMed ID: 25037541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
    Deo R; Khera A; McGuire DK; Murphy SA; Meo Neto Jde P; Morrow DA; de Lemos JA
    J Am Coll Cardiol; 2004 Nov; 44(9):1812-8. PubMed ID: 15519012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic factors and microinflammatory state promote kidney injury in type 2 diabetes mellitus patients.
    Cao C; Wan X; Chen Y; Wu W
    Ren Fail; 2009; 31(6):470-4. PubMed ID: 19839824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study.
    Foster MC; Hwang SJ; Porter SA; Massaro JM; Hoffmann U; Fox CS
    Hypertension; 2011 Nov; 58(5):784-90. PubMed ID: 21931075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study).
    Arsenault BJ; Kohli P; Lambert G; DeMicco DA; Laskey R; Messig MM; Kastelein JJ; Waters DD
    Am J Cardiol; 2016 Aug; 118(4):494-8. PubMed ID: 27328952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.